FDA Inspection 1141386 — Baptist Health Lexington IRB
The FDA completed an inspection of Baptist Health Lexington IRB on April 29, 2021 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 29, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, KY (United States)
Additional Details
IRB